HomeSWOBY • OTCMKTS
add
Swedish Orphan Biovitrum ADR
Nakaraang pagsara
$15.12
Sakop ng araw
$15.32 - $15.32
Sakop ng taon
$12.75 - $17.20
Market cap
96.43B SEK
Average na Volume
124.00
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.18B | 13.47% |
Gastos sa pagpapatakbo | 3.53B | 0.28% |
Net na kita | 636.00M | 183.93% |
Net profit margin | 10.30 | 150.00% |
Kita sa bawat share | 2.36 | 227.78% |
EBITDA | 2.14B | 37.10% |
Aktuwal na % ng binabayarang buwis | 20.15% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.06B | 35.82% |
Kabuuang asset | 68.75B | -6.04% |
Kabuuang sagutin | 29.68B | -19.38% |
Kabuuang equity | 39.07B | — |
Natitirang share | 344.61M | — |
Presyo para makapag-book | 0.13 | — |
Return on assets | 4.49% | — |
Return on capital | 5.94% | — |
Cash Flow
Net change in cash
| (SEK) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 636.00M | 183.93% |
Cash mula sa mga operasyon | 1.45B | -37.83% |
Cash mula sa pag-invest | -424.00M | -863.64% |
Cash mula sa financing | -988.00M | 51.62% |
Net change in cash | 61.00M | -75.79% |
Malayang cash flow | 888.38M | -60.42% |
Tungkol
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Itinatag
1939
Website
Mga Empleyado
1,937
